Literature DB >> 22139184

Crystallization and preliminary X-ray diffraction analysis of mouse prostaglandin F2α synthase, AKR1B3.

Yasuhide Takashima1, Seika Hatanaka, Eiichi Mizohata, Nanae Nagata, Yoshifumi Fukunishi, Hiroyoshi Matsumura, Yoshihiro Urade, Tsuyoshi Inoue.   

Abstract

Aldo-keto reductase 1B3 (AKR1B3) catalyzes the NADPH-dependent reduction of prostaglandin H(2) (PGH(2)), which is a common intermediate of various prostanoids, to form PGF(2α). AKR1B3 also reduces PGH(2) to PGD(2) in the absence of NADPH. AKR1B3 produced in Escherichia coli was crystallized in complex with NADPH by the sitting-drop vapour-diffusion method. The crystal was tetragonal, belonging to space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = b = 107.62, c = 120.76 Å. X-ray diffraction data were collected to 2.4 Å resolution at 100 K using a synchrotron-radiation source.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139184      PMCID: PMC3232157          DOI: 10.1107/S1744309111036165

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  19 in total

1.  Studies on pig muscle aldose reductase. Kinetic mechanism and evidence for a slow conformational change upon coenzyme binding.

Authors:  T J Kubiseski; D J Hyndman; N A Morjana; T G Flynn
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

2.  Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases.

Authors:  Kubata Bruno Kilunga; Tsuyoshi Inoue; Yousuke Okano; Zakayi Kabututu; Samuel K Martin; Michael Lazarus; Michael Duszenko; Yuichi Sumii; Yukiko Kusakari; Hiroyoshi Matsumura; Yasushi Kai; Shigeru Sugiyama; Kouji Inaka; Takashi Inui; Yoshihiro Urade
Journal:  J Biol Chem       Date:  2005-04-21       Impact factor: 5.157

3.  Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution.

Authors:  V Nahoum; A Gangloff; P Legrand; D W Zhu; L Cantin; B S Zhorov; V Luu-The; F Labrie; R Breton; S X Lin
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

4.  Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate.

Authors:  Y Jin; S E Stayrook; R H Albert; N T Palackal; T M Penning; M Lewis
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

5.  An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications.

Authors:  D K Wilson; K M Bohren; K H Gabbay; F A Quiocho
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

Review 6.  All in the family: aldose reductase and closely related aldo-keto reductases.

Authors:  J M Petrash
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

7.  Crystal structures of prostaglandin D(2) 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin.

Authors:  Andrew L Lovering; Jon P Ride; Christopher M Bunce; Julian C Desmond; Stephen M Cummings; Scott A White
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

Review 8.  Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Authors:  Trevor M Penning; Jason E Drury
Journal:  Arch Biochem Biophys       Date:  2007-05-11       Impact factor: 4.013

9.  Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7.

Authors:  Zakayi Kabututu; Michèle Manin; Jean-Christophe Pointud; Toshihiko Maruyama; Nanae Nagata; Sarah Lambert; Anne-Marie Lefrançois-Martinez; Antoine Martinez; Yoshihiro Urade
Journal:  J Biochem       Date:  2008-11-14       Impact factor: 3.387

10.  Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.

Authors:  Oriol Gallego; F Xavier Ruiz; Albert Ardèvol; Marta Domínguez; Rosana Alvarez; Angel R de Lera; Carme Rovira; Jaume Farrés; Ignacio Fita; Xavier Parés
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.